T1	Treatment 0 58	Granulocyte-macrophage colony-stimulating factor treatment
T2	Treatment 230 278	granulocyte-macrophage colony-stimulating factor
T3	Treatment 586 648	four courses of cyclophosphamide and doxorubicin chemotherapy.
T4	Treatment 712 799	subjects received GM-CSF priming on days 5 to 1 for courses 1 and 3 or courses 2 and 4.
T5	Treatment 2384 2397	chemotherapy.
